Evidence map›Paper›PMID 34696691›Full record

ReviewExpert opinion on drug delivery2021

Therapeutic nanocarriers comprising extracellular matrix-inspired peptides and polysaccharides.

Lucas C Dunshee, Millicent O Sullivan, Kristi L Kiick

Abstract readReview
In one paragraph

Review in Expert opinion on drug delivery, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Targeting breast tumor extracellular matrix and stroma utilizing nanoparticles.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Review
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Lucas C DunsheeDepartment of Chemical and Biomolecular Engineering, University of Delaware, Newark, DE, USA.ORCID 0000-0001-6025-5222
Millicent O SullivanDepartment of Chemical and Biomolecular Engineering, University of Delaware, Newark, DE, USA.
Kristi L KiickDepartment of Biomedical Engineering, University of Delaware, Newark, DE, USA.

Funding

Collagen turnover-stimulated gene delivery to enhance chronic wound repairR01AR067247 · NIAMS · UNIVERSITY OF DELAWARE · PI KIICK, KRISTI L, MARGOLIS, DAVID · 2016 to 2019
$1.4M
Collagen-based targeting for improving delivery and efficacy of osteoarthritis drugsR21AR069778 · NIAMS · UNIVERSITY OF DELAWARE · PI KIICK, KRISTI L, PRICE, CHRISTOPHER · 2017 to 2018
$365k
NIAMS NIH HHS R01 AR067247NIAMS NIH HHS R21 AR069778
6 · The paper itself

Abstract

introductionThe extracellular matrix (ECM) is vital for cell and tissue development. Given its importance, extensive work has been conducted to develop biomaterials and drug delivery vehicles that capture features of ECM structure and function. AREAS COVERED: This review highlights recent developments of ECM-inspired nanocarriers and their exploration for drug and gene delivery applications. Nanocarriers that are inspired by or created from primary components of the ECM (e.g. elastin, collagen, hyaluronic acid (HA), or combinations of these) are explicitly covered. An update on current clinical trials employing elastin-like proteins is also included. EXPERT OPINION: Novel ECM-inspired nanoscale structures and conjugates continue to be of great interest in the materials science and bioengineering communities. Hyaluronic acid nanocarrier systems in particular are widely employed due to the functional activity of HA in mediating a large number of disease states. In contrast, collagen-like peptide nanocarriers are an emerging drug delivery platform with potential relevance to a myriad of ECM-related diseases, making their continued study most pertinent. Elastin-like peptide nanocarriers have a well-established tolerability and efficacy track record in preclinical analyses that has motivated their recent advancement into the clinical arena.

Indexed as

ElastinExtracellular MatrixCollagenHyaluronic AcidPeptidesCollagenElastinHyaluronic AcidPeptidesArthritiscancercollagen-like peptidesdrug deliveryelastin-like peptidesextracellular matrixgene deliveryhyaluronic acidnanocarriersosteoarthritisrheumatoid arthritiswound healing

Identifiers

PMID34696691
PMCPMC8601199

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.